Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
   
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  Antibodies
  Mutations
  AlzGene
  Research Models
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Expert Opinion
  Ask the Expert
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: Research: Compendia: Research Models
Alpha-Synuclein Research Models

Updated 14 April 2005

back to Research Models Index

Viewing tips: Make your browser window wide enough to view the table, which should fit on most standard monitors. 

 
Name/
Symbol
Strain Name Transgene/
Promoter and Regulatory Elements
Genetic Background Behavioral 
Phenotype
Neurological 
Characteristics
Patents/ 
Availability
Primary Citation
A53T αsynuclein PRP transgenic-/-
(See JAX datasheet)

Symbol: SNCA

Posted 5/19/04

B6;C3H-Tg(SNCA)83Vle/J Mouse Prnp, prion protein promoter/ human α-synuclein A53T mutation cDNA /B6C3H mouse eggs. Origin: Backcross N?+N1 Homozygous mice are viable, fertile and normal in size. By 16 months display severe motor phenotype. Lax grooming, weight loss and diminished mobility precede movement impairment, partial limb paralysis, trembling and inability to stand. 8 to 12 months widely distributed α-synuclein inclusions, with dense accumulation in the spinal cord, brainstem, cerebellum and thalamus. This parallels the onset of the motor impairment phenotype. Axons and myelin sheaths exhibit progressive ultrastructural degeneration. Available
The Jackson Lab: Stock 004479
Giasson et al., 2002
Alpha Synuclein   Human alpha-synuclein cDNA with A53T mutation/
Thy1 gene promoter
C57BL/6 An early-onset (>3 weeks of age) and a progressive decline of motor function caused by severe degeneration of neuromuscular junctions. Increased levels of a-synuclein protein in brain found in neurons throughout the telencephalon, brainstem, and spinal cord. Also showed astrocytic gliosis and microglial activation. Many of the cells showed diffuse perikaryal a-synuclein staining. Intense staining with the Campbell-Switzer pyridine silver, a routine and sensitive method used to detect Lewy-type changes in human brain tissue. Unpatented van der Putten H et al., 2000;

Sommer B et al., 2000

(PLP)-h[wt] αSYN

Symbol: αSYN

Updated 4/14/05

  Human wt αSYN / proteolipid protein promoter (PLP)/injected into C57BL/6 DBA/2 fertilized eggs. Origin: C57BL/6. Backcross generation N7   Transgenic SYN was detected in brain white matter and oligodendrocytes, detergent insoluble. Hyperphosphorylation at S129 of SYN in the tg mice. Contact Philipp Kahle
at pkahle@pbm.med.uni-muenchen.de
Kahle et al., 2002
(TH)-h[A30P] SYN

Symbol: αSYN

Posted 7/9/04

  human mutant [A30P] SYN sequence was cloned into a cassette with 4.5-kb 5' flanking DNA from rat TH gene promotor/Injected DBA X C57BL/6 eggs. Origin: C57BL/6; Backcrossed to 4 generations No motor disability Tg mice showed somal and neuritic accumulation of transgenic A30P SYN in TH-positive neurones in the substantia nigra. No difference in the number of TH-positive neurones or concentrations of catecholamines between tg mice and non-tg littermates. Contact Philipp Kahle
at pkahle@pbm.med.uni-muenchen.de
Rathke-Hartlieb et al., 2001
(Thy1)-h[A30P] SYN

Updated 4/14/05

  The amplified human [wt]Alpha-SYN-coding sequence with A30P mutation/ neuron specific Thy1 promoter Backcrossed N > 8 generations C57BL/6J, (2002) No overt motor abnormalities to 1 year of age. Shows age-gene-dose dependent lethal locomotor deterioration along with Lewy pathology. Mutant hα-SYN found in synapses, and positive neurites exhibit Lewy body characteristics. Shows age- and gene dose- dependent development of Lewy pathology. Unpatented

Contact: Philipp Kahle

Kahle et al., 2000
(Thy1)-h[wt] αSYN

Updated 11/4/03

  human wild-type α-SYN cDNA C57BL/6 None listed. hα-SYN initially undetectable but then increased to plateau at 1 month, expression was 3 fold of endogenous α-SYN. Abnormal Tg α-syn-positive neurites were seen. Tg α-syn found in detergent-insoluble tissue fractions.

Contact: Philipp Kahle

Kahle et al., 2001

Copyright © 1996-2008 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad